Myotonic Muscular Dystrophy Market
Muscular dystrophy, or myotonic dystrophy, refers to a series of long-term hereditary illnesses that affect functions of the muscle. Muscle atrophy and weakness develop with time as a symptom. Muscles are unable to relax and contract often. Cardiac conduction abnormalities, intellectual impairment, and cataracts are all potential signs. Early baldness and infertility in males could also comprise side effects. Myotonic dystrophy affects one out of every 8,000 persons on the planet. Myotonic dystrophy can strike at any age, though it usually strikes in the 20s and 30s. It's the most frequent type of muscular dystrophy that strikes adults. The growing prevalence of this disease is anticipated to work in favour of the global myotonic muscular dystrophy market in the forthcoming years.
The global myotonic dystrophy market is anticipated to expand due to the launch of innovative disease therapies and increased research and development activities. In addition to that, a rise in the incidences of myotonic dystrophy along with increasing demand for effective treatment methods is estimated to drive the demand in the said market. Wider coverage in healthcare insurance and incidences of chronic illnesses like arthritis, neurovascular, and cardiovascular conditions are further expected to augur well for the global myotonic dystrophy market in the near future.
Myotonic muscular dystrophy (DMD) is a genetic disorder characterized by muscle degeneration and weakness. It is a common form of muscular dystrophy that generally begins in adulthood. Myotonic dystrophy can be categorized into myotonic dystrophy type 1 (DM1) and myotonic dystrophy type 2 (DM2). Myotonic dystrophy type 1 (DM1) is result of an abnormal DNA expansion in the DMPK gene on chromosome 19. Myotonic dystrophy type 2 (DM2) is caused by an abnormal expansion of DNA in the ZNF9 gene on chromosome 3. Myotonic dystrophy (DM) 1 is sub divided into congenital-onset DM1, juvenile-onset DM1, and adult-onset DM1. Common symptoms of myotonic dystrophy include stiffness and tightness of muscles, progressive muscle wasting, and muscle weakness in lower legs, neck, hands, and face. Abnormalities in parts of brain, cataracts, heart difficulties, insulin resistance, and limb and hand muscle weakness are also symptoms of myotonic dystrophy. Cognitive disabilities in congenital myotonic dystrophy, outgrowing congenital myotonic dystrophy, speech, hearing, and vision difficulties, and weak muscles are the common symptoms of congenital myotonic dystrophy1. Neuromuscular health care professionals diagnosed myotonic dystrophy with the help of sign and symptoms of people. Doctors also used electromyogram or EMG for electrical testing of muscles and nerves. DNA test is recommended by the health care specialists to confirm suspects of DM1 or DM2.
Increase in research and development, introduction of novel disease therapies, rise in demand for effective therapies among patients, and upsurge in prevalence of the disease are projected to fuel the growth of the global myotonic dystrophy market during the forecast period. According to the Centers for Disease Control and Prevention, in 2016, prevalence of myotonic muscular dystrophy was 1 in every 8000 people. Rise in prevalence of chronic diseases such as cardiovascular, neurovascular, and arthritis and increase in health care insurance coverage are the other factors estimated to accelerate the growth of the global myotonic muscular dystrophy market during the forecast period. According to the World Health Organization, cardiovascular diseases accounted for 17.7 million deaths in 2015, representing 31% of the global deaths.
The global myotonic muscular dystrophy market can be segmented based on medical treatment, end-user, and region. In terms of medical treatment, the myotonic muscular dystrophy market can be categorized into medications, rehabilitative therapies, devices, and surgeries. Based on end-user, the myotonic muscular dystrophy market can be classified into hospitals, specialty clinics, and ambulatory surgery centers. In term of revenue, the hospitals segment dominate the myotonic muscular dystrophy market in 2016.
Geographically, the global myotonic muscular dystrophy market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the leading market for myotonic muscular dystrophy globally. In terms of revenue, the U.S. accounts for a major share of the myotonic muscular dystrophy market in North America. The myotonic muscular dystrophy market in Europe is expanding rapidly due to high prevalence of the disease in the region. The myotonic muscular dystrophy market in Asia Pacific and Latin America is projected to expand significantly in the near future. Developing economies such as China and India are anticipated to contribute to the growth of the myotonic muscular dystrophy market in Asia Pacific between 2017 and 2025 due to developed health care infrastructure, economic growth, increase in the number of insurance payers, growth of the private health care sector, and rise in disease awareness among the people in the region. Brazil and Mexico dominate the myotonic muscular dystrophy market in Latin America in terms of treatment of the disease. In Middle East & Africa, South Africa, Turkey, and other developing countries contribute to the growth of the myotonic muscular dystrophy market in the region.
Key players operating in the myotonic muscular dystrophy market are Pfizer, Inc., Eli Lilly and Company, Mylan Pharmaceuticals Inc., Wockhardt Ltd., Teva Pharmaceutical Industries Ltd., Novartis AG, BioMarin Pharmaceutical, Inc., Asklepios Kliniken GmbH, Hoveround Corporation, and Siemens Healthcare.
This upcoming business intelligence report is intended to be a one-stop market research solution to guide organizations in taking timely and effective decisions for their business growth. The ongoing study is the culmination of our deep expertise on data science methods, combined with an unparalleled understanding of the external environment and analysis of the industries. Each of the reports by TMR aims at offering a detailed scrutiny of the value chain of our current and prospective customers, takes them from identifying value propositions, and subsequently assist their business executives to implement right strategies to create customer value. We believe that creating and sustaining the customer value is the key pivot on which business executives can create profits for their organizations and increase the market shares, continuously and with sustainability.
Each of our touchpoints through which we engage with the organization/enterprise during the primary research enables us to understand the internal environment it operates in and the ways in which the external environment influences its growth.
Always Evolving with Competition
Excellence is built into the DNA of TMR, and all our teams work collaboratively and committedly toward achieving that in whatever they do. From the very first interaction our teams of research analysts have with any interested market participant to the final preparation processes in each of our reports reflects a rigorous understanding of the dynamic industry environment that businesses operate in.
We relentlessly work to be a differentiator in whatever we do in the current era of hypercompetitive global environment. The result of our unceasing focus on excellence is reflected clearly in the insights and guidance we offer to our customers in order to empower them to create brand equity. Our simple yet very powerful underpinning for navigating the competition is to always keep evolving with changing business environments. Our close-kinit team of research analysts not only believe in this simple philosophy but also implement the same.
Constantly Innovating Our Research Methodologies and Models
We do not limit with any specific market research tool or one standard approach for obtaining or analyzing data. Undoubtedly, our report making process is ever-evolving to meet the customer needs and demands supported broadly by a vast knowledge of data science methods that we combine with business acumen our teams have built upon for several years. Evidently, our primary and secondary research data about customers and consumers have shown that we can go to any lengths to obtain them. This is followed by applying next-gen automation tools integrated with human judgement to clear the clutter, ascertain the most relevant and recent qualitative and quantitative insights, and package them in digestible chunks in our reports for our customers.
We Take Pride in No-One-Size-Fits-All Approach
Over the past several years, we have been conducting market intelligence studies across all industries for all types of organizations — big and small, profit and not-for-profit, and Fortune 500 and Unicorns, as we believe that a sound decision making must be based on no-one-size-fits-all approach. Without doubt, each of the organizations regardless of the industry they are in are affected differently by changes in political, economic, socio-culture, legal, ecological, and legal environments. The research models and the value chain analysis process that our analysts employ for conducting the study uphold this approach.
We look at myriad components of internal and external business environment affecting the growth strategies of organizations. Some of the broader aspects that we focus on are:
- Our team of Analysts and Support Teams always strive to see the bigger picture in life cycle stages of any industry
- The Teams focus on obtaining valuable insights into different models of competitive advantage while making an internal environment analysis
- They keep on modifying the value chain analysis processes of organizations to understand on how customer value is created
Some areas of assessing market dynamics that are used in the research models and methodologies adopted by our analysts can be summarized as:
- Corporate and business strategies underlying new brand positioning strategies
- Mapping for strategic planning for business units
- Various metrics for business portfolio analysis, including BCG matrix
- Value chain analysis
These will help create and sustain competitive advantage for our prospects and current customers.
Key focus areas and agenda that underpin and catalyze our primary and secondary research initiatives and endeavors are:
- What are some of the core competencies and distinctive competencies of new entrants and established players in the industry we are analyzing?
- What are some of the branding opportunities that are emerging at a rapid pace?
- What are the major competitive forces and elements of external environment shaping the industry life cycle stages of most organizations?
- Why some competitive strategies are popular than others among leaders in a certain market?
- What customer-based brand equity strategies companies have leveraged in a certain industry or set of related industries in a sector?
- What are some of the key pricing strategies that companies in an industry are implementing for marketing their products internationally?
- Identifying whether market-push or market-pull strategies are more relevant to a certain product or a service?
Disclaimer: This ongoing market research study is a meticulously planned activity where a broad array of factors and aspects that shape the marketing environment and industry are taken into account. However, keeping in mind the constantly changing nature of business dynamics and changing strategic intents, we are always actively making iterations and modifications in our approaches. As always, we are ready to tailor our insights and guidance to suit your requirements. Engage with us to know what more is there for your CXOs.